Dyne Therapeutics to Present at Morgan Stanley 21st Annual Global Healthcare Conference
05.09.2023 - WALTHAM, Mass., Sept. 05, 2023 (GLOBE NEWSWIRE) - Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, ...